Helen Demarest is the Senior Director Clinical Operations at Medicines for Malaria Venture (MMV) based in Geneva, Switzerland. MMV is a public-private partnership with a mission to develop new, effective and affordable medicines for malaria patients in endemic countries. She is responsible for efficient, compliant, innovative study planning and execution; delivering reliable data across the MMV portfolio to advance its mission and vision, and work towards a malaria free world.
Prior to joining MMV in 2012 and pursuing her interest in Global Health, she spent >10 years in the clinical research industry working across all phases of drug development. She started her career in a global CROs holding a variety of positions encompassing monitoring, project management, quality assurance and compliance. She then moved to academia working in trial management for Oxford University in the UK before moving to MMV. She obtained a PhD degree from the Royal Veterinary College, University of London, and a Bachelor’s degree in Zoology and Psychology from the University of Reading, UK.